TIE2 Anti-TIE2 antibody and Use Thereof
The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood vessel normalization and stabilization through receptor phosphorylation. More particularly, the present invention relates to: an anti-TIE2 antib...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
24.02.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood vessel normalization and stabilization through receptor phosphorylation. More particularly, the present invention relates to: an anti-TIE2 antibody; a nucleic acid encoding the same; a vector comprising the nucleic acid; a cell transformed with the vector; a method for preparing the antibody; an agent for stabilizing blood vessels and a composition for treating angiogenesis-associated diseases, both of which comprise the antibody; and a composition for co-administration with a pharmaceutical composition for tumor or cancer treatment and with a composition other than an antibody binding to TIE2.
본 발명은 TIE2 (Tyrosine-protein kinase receptor TIE-2)에 특이적으로 결합하여 수용체의 인산화를 통해 혈관을 정상화(vessel normalization)하고, 안정화 (stabilization)시키는 기능을 보유한 항체와 관련된 것으로, 항-TIE2 항체, 이를 코딩하는 핵산, 상기 핵산을 포함하는 벡터, 상기 벡터로 형질전환된 세포, 상기 항체의 제조방법, 이를 포함하는 혈관안정화제 및 신생혈관형성(angiogenesis)과 관련된 질병의 치료용 조성물, 종양 또는 암 치료용 약학적 조성물 및 TIE2에 결합하는 항체 이외의 조성물과의 병용투여용 조성물에 관한 것이다. |
---|---|
AbstractList | The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood vessel normalization and stabilization through receptor phosphorylation. More particularly, the present invention relates to: an anti-TIE2 antibody; a nucleic acid encoding the same; a vector comprising the nucleic acid; a cell transformed with the vector; a method for preparing the antibody; an agent for stabilizing blood vessels and a composition for treating angiogenesis-associated diseases, both of which comprise the antibody; and a composition for co-administration with a pharmaceutical composition for tumor or cancer treatment and with a composition other than an antibody binding to TIE2.
본 발명은 TIE2 (Tyrosine-protein kinase receptor TIE-2)에 특이적으로 결합하여 수용체의 인산화를 통해 혈관을 정상화(vessel normalization)하고, 안정화 (stabilization)시키는 기능을 보유한 항체와 관련된 것으로, 항-TIE2 항체, 이를 코딩하는 핵산, 상기 핵산을 포함하는 벡터, 상기 벡터로 형질전환된 세포, 상기 항체의 제조방법, 이를 포함하는 혈관안정화제 및 신생혈관형성(angiogenesis)과 관련된 질병의 치료용 조성물, 종양 또는 암 치료용 약학적 조성물 및 TIE2에 결합하는 항체 이외의 조성물과의 병용투여용 조성물에 관한 것이다. |
Author | YOO JIN SAN KIM DO YUN PARK BEOM YONG LEE EUN AH LEE WEON SUP KANG NU RI LEE YOUNGAE PARK CHEONHO |
Author_xml | – fullname: PARK CHEONHO – fullname: YOO JIN SAN – fullname: PARK BEOM YONG – fullname: LEE WEON SUP – fullname: LEE EUN AH – fullname: KANG NU RI – fullname: LEE YOUNGAE – fullname: KIM DO YUN |
BookMark | eNrjYmDJy89L5WRQD_F0NVJwzCvJ1AWzEoGspPyUSiAjRSG0OFUhJCO1KDU_jYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxHsHGRkYGRoYGBlYGFs6GhOnCgBPuyim |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
DocumentTitleAlternate | 항-TIE2 항체 및 이의 용도 |
ExternalDocumentID | KR20210020839A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_KR20210020839A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:46:06 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_KR20210020839A3 |
Notes | Application Number: KR20200102688 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210224&DB=EPODOC&CC=KR&NR=20210020839A |
ParticipantIDs | epo_espacenet_KR20210020839A |
PublicationCentury | 2000 |
PublicationDate | 20210224 |
PublicationDateYYYYMMDD | 2021-02-24 |
PublicationDate_xml | – month: 02 year: 2021 text: 20210224 day: 24 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | PHARMABCINE INC |
RelatedCompanies_xml | – name: PHARMABCINE INC |
Score | 3.2796688 |
Snippet | The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
Title | TIE2 Anti-TIE2 antibody and Use Thereof |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210224&DB=EPODOC&locale=&CC=KR&NR=20210020839A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU8BtjqMzJJ0gfKJuibGaam6SabmabppBkkpyaBUYGQJ2u_s62fmEWriFWEawcSQA9sLAz4ntBx8OCIwRyUD83sJuLwuQAxiuYDXVhbrJ2UChfLt3UJsXdSgvWNw_8VEzcXJ1jXA38XfWc3Z2dY7SM0vCCIHupDS2NKRmYEV1JAGnbTvGuYE2pdSgFypuAkysAUAzcsrEWJgys4XZuB0ht29JszA4Qud8hZmYAev0UwuBgpC82GxCIN6iKerkYJjXkmmLpgFDJ7MpPyUSiAjRSG0OFUBGPtFqflpogzKbq4hzh66QLvj4V6N9w5CdqixGANLXn5eqgSDgmGKmWmKqXGymXmqgYmJUSqwGk9OTQPmNyOTFENDSxNJBhl8Jknhl5Zm4AJxwVu1TWQYWEqKSlNlgZVtSZIcOIwAhnR_cg |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_m_JhvOhU_phaU-lTc2rRlD0O2ftDZfVE62VtZmxSG0o61Iv73XuKme9pbuB9ckksul4-7C8CjSXHXoRqxgvhcIVrKlFg3UyVtxjThs0Bt83jn4cjwpuR1ps8q8LGJhRF5Qr9EckTUqAT1vRTr9fL_EssWvpXFc7xAUv7ihh1bXp-OxfmFyHav40zG9tiSLavjB_Io-MX4h5Rau7sH-ybPz8s3T289Hpey3DYq7gkcTJBfVp5C5T2vQ83a_L1Wh6Ph-sm7DofCRzMpkLjWw-IMnsK-o0rdrFwoooTiWcQ5_cYClaYFk3D0VyxPz-HBdULLU7Du6K-rkR9sN1S7gGqWZ-wSpBY1dKpriWGyJiEqQzOesBT1TSW01WqTK2js4nS9G76HmhcOB9GgP_Jv4JhDImybNKBarj7ZLRreMr4T8voBpMuCXw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TIE2+Anti-TIE2+antibody+and+Use+Thereof&rft.inventor=PARK+CHEONHO&rft.inventor=YOO+JIN+SAN&rft.inventor=PARK+BEOM+YONG&rft.inventor=LEE+WEON+SUP&rft.inventor=LEE+EUN+AH&rft.inventor=KANG+NU+RI&rft.inventor=LEE+YOUNGAE&rft.inventor=KIM+DO+YUN&rft.date=2021-02-24&rft.externalDBID=A&rft.externalDocID=KR20210020839A |